Innovation is a theme of FI Center and of FISpace. It’s also a topic getting attention today nationally because, whatever their position on the “offshoring” issue, virtually everyone agrees that future prosperity in the US depends on being innovative, not on commodity ideas and labor. Also, the pharmaceutical industry about which I’m writing is having a crisis over innovation—or, rather, ...

Best practices articel from onPhilanthropy asks the question: Is your donor base as diverse as the population you serve: Some quotes:

I said in my previous post that I’m working on a report about the life sciences industry. The objectives I’ve ste for the report follow. Again, I invite your input about them.

When the Futuring and Innovation Center started, I asked to specialize in looking into the life sciences field and its implications for the future of the Society’s mission. I did it because I was interested in it and because, here in California, biotech and associated enterprises is a major industry. I will be eternally grateful to my boss, Pat, and ...